
Neutrogena addresses backlash after claims it dropped Hayden Panettiere over postpartum depression
Skincare brand Neutrogena issued a public statement and pledged healthcare funding following boycott calls after the death of actress Hayden Panettiere at age 36.
Public outcry and boycott calls
Following the death of actress Hayden Panettiere on 16 August 2026 at age 36, cosmetics brand Neutrogena faced widespread social media criticism and calls for a consumer boycott. Online users and content creators, including influencer Érica Ann with over 700,000 followers, shared videos discarding Neutrogena products. The anger followed the recirculating of remarks Panettiere made earlier in the year regarding the termination of her decade-long contract with the company. Commentators linked the end of the commercial relationship to her decision to speak publicly about her postpartum depression.
Contract termination and disclosure
Panettiere served as a primary advertising face for Neutrogena between 2005 and 2015. After giving birth to her daughter Kaya in 2014, the actress experienced severe postpartum depression and entered treatment in 2015 when the child was four months old. Panettiere discussed her condition on the morning talk show Live with Kelly and Michael, but she subsequently received notice that Neutrogena would not continue their partnership. In her May 2026 memoir, This Is Me: A Reckoning, and an interview on Jay Shetty's podcast On Purpose, she described how the company invoked contract morality clauses to drop her.
I had my daughter and I knew something was just terribly, terribly wrong.
She stated that she had worked with the brand for ten years, yet nobody from the company reached out personally after letting the contract lapse. Panettiere also recounted that she turned to alcohol and opioids to self-medicate during that period.
- Panettiere becomes a brand ambassador for Neutrogena
- Panettiere gives birth to her daughter Kaya
- Panettiere speaks publicly on postpartum depression and Neutrogena ends the contract
- Panettiere details the contract termination in her memoir and on Jay Shetty's podcast
- Panettiere dies at age 36 with causes undisclosed
- Neutrogena issues a statement on Instagram and pledges maternal healthcare funding
Corporate response and health investment
On 20 August 2026, four days after Panettiere's death, Neutrogena published a statement on Instagram with comments disabled. The company acknowledged that its past actions failed to provide adequate backing to the actress during a period of personal difficulty.
We are proud to have partnered with her and understand that we made her feel unsupported. This is not what Neutrogena stands for or who we want to be.
The brand announced plans for a financial investment in a long-time community health partner to broaden access to women's healthcare, including postpartum depression treatments. Neutrogena noted that it delayed making a public statement out of respect for Panettiere's family.
Maternal mental health discussions
Postpartum depression affects between 10% and 15% of women who give birth in the United States, according to public health figures cited during the controversy. The resurfaced interview renewed wider discussions regarding the stigmas associated with maternal mental illness and corporate conduct toward vulnerable spokespersons. Michelle Battersby, president of the maternal networking app Peanut, noted that Panettiere's experience resonated with many mothers facing similar emotional struggles after childbirth.
Can we be surprised when women then don't speak about their postpartum suffering or their mental health?
Battersby stated that Panettiere had repeatedly sought assistance before facing professional abandonment, pointing to ongoing barriers that discourage mothers from openly discussing psychological challenges.

